Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176554 | SCV000228229 | pathogenic | not provided | 2017-03-05 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000176555 | SCV000255721 | pathogenic | Duchenne muscular dystrophy | 2013-08-27 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000176554 | SCV002019412 | pathogenic | not provided | 2019-09-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000176555 | SCV002179280 | pathogenic | Duchenne muscular dystrophy | 2023-12-09 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 25 of the DMD gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Becker muscular dystrophy (PMID: 16834926, 19001018, 19783145). This variant is also known as IVS25+1G>A. ClinVar contains an entry for this variant (Variation ID: 94589). Studies have shown that disruption of this splice site results in skipping of exon 25, but is expected to preserve the integrity of the reading-frame (PMID: 19001018, 19783145). For these reasons, this variant has been classified as Pathogenic. |